List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 384 studies with search of: Lamivudine
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
Condition: Chronic Hepatitis B
Interventions: Drug: Lamivudine plus Polyethylene glyco-interferon alfa-2b;   Drug: Lamivudine
2 Enrolling by invitation Pharmacokinetics of Lamivudine at Two Different Doses
Condition: Healthy
Interventions: Drug: 3TC 300 mg once daily orally;   Drug: 3TC 150 mg once daily
3 Active, not recruiting Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
Condition: HIV-1
Interventions: Drug: Maraviroc + Zidovudine/Lamivudine;   Drug: Efavirenz + Zidovudine/Lamivudine;   Drug: Maraviroc (UK-427,857) + Zidovudine/Lamivudine
4 Active, not recruiting Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
5 Active, not recruiting Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
6 Completed Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
7 Active, not recruiting Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Condition: HIV Infection
Interventions: Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV x 48wks;   Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV/r x 48wks
8 Recruiting Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
9 Recruiting Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
10 Recruiting Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
11 Active, not recruiting Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
Condition: HIV Infections
Interventions: Drug: Viread (tenofovir disoproxil fumarate);   Drug: Sustiva (Efavirenz);   Drug: Epivir (Lamivudine);   Drug: Zerit (Stavudine)
12 Completed To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
Condition: HIV
Interventions: Drug: Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks;   Drug: Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks;   Drug: Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks
13 Recruiting Efficacy of Clevudine Plus Lamivudine for Lamivudine-Resistant Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: adefovir;   Drug: clevudine;   Drug: lamivudine
14 Completed 3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections
Interventions: Drug: Lamivudine;   Drug: Zidovudine
15 Completed The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Lamivudine;   Drug: Zidovudine
16 Recruiting Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
17 Completed Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
Condition: HIV Infections
Interventions: Drug: Lamivudine, nevirapine, and stavudine fixed-dose tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Stavudine
18 Recruiting Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Tenofovir;   Drug: Adefovir;   Drug: Lamivudine
19 Recruiting Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: combination of lamivudine+adefovir vs entecavir
20 Not yet recruiting Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: Lamivudine (3TC)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services